Complement-fixing islet cell antibodies in type-1 diabetes can trigger the assembly of the terminal complement complex on human islet cells and are potentially cytotoxic

O. Radillo, A. Nocera, A. Leprini, S. Barocci, T. E. Mollnes, M. Pocecco, M. Pausa, U. Valente, C. Betterle, F. Tedesco

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Complement-fixing islet cell antibodies in type-1 diabetes can trigger the assembly of the terminal complement complex on human islet cells and are potentially cytotoxic'. Together they form a unique fingerprint.

Medicine & Life Sciences